SARS-CoV-2-specific T cell responses and immune regulation in infected pregnant women Journal of Reproductive Immunology
暂无分享,去创建一个
J. Sidney | A. Grifoni | A. Franco | Jennifer A Zellner | Li-En Hsieh | Hiral M. Dave | Diana H. Johnson | Jasmine Wang | C. Chambers
[1] J. Sidney,et al. Characterization of SARS‐CoV‐2 and common cold coronavirus‐specific T‐cell responses in MIS‐C and Kawasaki disease children , 2021, European journal of immunology.
[2] S. Mallal,et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2021, Cell Reports Medicine.
[3] S. Mallal,et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2020, bioRxiv.
[4] E. Olsen,et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[5] E. Olsen,et al. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[6] M. Kikkert,et al. Detailed immune monitoring of a pregnant woman with critical Covid-19 , 2020, Journal of Reproductive Immunology.
[7] M. Lipsitch,et al. Cross-reactive memory T cells and herd immunity to SARS-CoV-2 , 2020, Nature Reviews Immunology.
[8] S. McLafferty,et al. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[9] J. Greenbaum,et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity , 2020, Cell.
[10] S. Mallal,et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans , 2020, Science.
[11] A. Sette,et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome , 2020, Science Immunology.
[12] S. Gilboa,et al. Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[13] S. Farhadian,et al. SARS-CoV-2 infection of the placenta. , 2020, The Journal of clinical investigation.
[14] J. Greenbaum,et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.
[15] A. Benachi,et al. Transplacental transmission of SARS-CoV-2 infection , 2020, Nature Communications.
[16] Xiaobao Ying. SARS-CoV-2 Infection , 2020 .
[17] A. Franco. Immune Regulation is the Most Relevant Arm of the Immune Response in Infants and Young Children. , 2020, Critical reviews in immunology.
[18] R. Xu,et al. Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study , 2019, PloS one.
[19] C. Chambers,et al. Approach to evaluating pregnancy safety of anti-rheumatic medications in the OTIS MotherToBaby pregnancy studies: what have we learned? , 2018, Rheumatology.
[20] C. Chambers,et al. Autoimmune conditions and comorbid depression in pregnancy: examining the risk of preterm birth and preeclampsia , 2017, Journal of Perinatology.
[21] R. Rizzo,et al. HLA-G expression levels influence the tolerogenic activity of human DC-10 , 2015, Haematologica.
[22] P. Panina-Bordignon,et al. HLA-G Orchestrates the Early Interaction of Human Trophoblasts with the Maternal Niche , 2015, Front. Immunol..
[23] J. Kanegaye,et al. Immune‐monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin , 2013, Clinical and experimental immunology.
[24] A. Mitchell,et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. , 2013, Vaccine.
[25] M. Roncarolo,et al. HLA-G expressing DC-10 and CD4+ T cells accumulate in human decidua during pregnancy , 2013, Human immunology.
[26] Adrian Erlebacher,et al. Immunology of the maternal-fetal interface. , 2013, Annual review of immunology.
[27] Jeff E. Mold,et al. Immunological tolerance during fetal development: from mouse to man. , 2012, Advances in immunology.
[28] E. Hauben,et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. , 2010, Blood.
[29] R. Xu,et al. Birth outcomes in women who have taken leflunomide during pregnancy. , 2010, Arthritis and rheumatism.
[30] Shimon Sakaguchi,et al. Regulatory T cells exert checks and balances on self tolerance and autoimmunity , 2010, Nature Immunology.
[31] M. Battaglia,et al. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans , 2007, Nature Reviews Immunology.
[32] K. Red-Horse,et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. , 2004, The Journal of clinical investigation.
[33] R. K. Miller,et al. Postmarketing surveillance for human teratogenicity: a model approach. , 2001, Teratology.
[34] S. Voß,et al. Postmarketing surveillance , 1994, BMJ.